Management strategies for acute infective conjunctivitis in primary care: a systematic review

Bibliography

• DART JK: Eye disease at a community health centre. Br. Med. J. (Clin. Res. Ed.) (1986) 293(6560):1477-1480.
   PubMed Web of Science ®Google Scholar
• MCDONNELL PJ: How do general practitioners manage eye disease in the community? Br. J. Ophthalmol. (1988) 72(10):733-736.
   PubMed Web of Science ®Google Scholar
• MCCORMICK M FDCJ: Morbidity statistics from general practice: fourth national survey 1991 – 1992. London: HMSO (1995).
   Google Scholar
• EVERITT H, LITTLE P: How do GPs diagnose and manage acute infective conjunctivitis? A GP survey. Fam. Pract. (2002) 19(6):658-660.
   PubMed Web of Science ®Google Scholar
• EVERITT H, KUMAR S, LITTLE P: A qualitative study of patients' perceptions of acute infective conjunctivitis. Br. J. Gen. Pract. (2003) 53(486):36-41.
   PubMed Web of Science ®Google Scholar
• DEPARTMENT OF HEALTH: Prescription cost analysis: England (2004).
   Google Scholar
• ROSE PW, ZIEBLAND S, HARNDEN A, MAYON-WHITE R, MANT D: Why do general practitioners prescribe antibiotics for acute infective conjunctivitis in children? Qualitative interviews with GPs and a questionnaire survey of parents and teachers. Fam. Pract. (2005) 23(2):226-232.
   PubMed Web of Science ®Google Scholar
• CAGLE GD, ABSHIRE RL: Quantitative ocular bacteriology: a method for the enumeration and identification of bacteria from the skin-lash margin and conjunctiva. Invest. Ophthalmol. Vis. Sci. (1981) 20(6):751-757.
   PubMed Web of Science ®Google Scholar
• LEIBOWITZ HM: Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am. J. Ophthalmol. (1991) 112(4 Suppl.):S34-S47.
   Web of Science ®Google Scholar
• ROSE PW, HARNDEN A, BRUEGGEMANN AB et al.: Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet (2005) 366(9479):37-43.
   PubMed Web of Science ®Google Scholar
• SEAL DV, BARRETT SP, MCGILL JI: Aetiology and treatment of acute bacterial infection of the external eye. Br. J. Ophthalmol. (1982) 66(6):357-360.
   PubMed Web of Science ®Google Scholar
• PERKINS RE, KUNDSIN RB, PRATT MV, ABRAHAMSEN I, LEIBOWITZ HM: Bacteriology of normal and infected conjunctiva. J. Clin. Microbiol. (1975) 1(2):147-149.
   PubMed Web of Science ®Google Scholar
• RIETVELD RP, TER RIET G, BINDELS PJ, BINK D, SLOOS JH, VAN WEERT HC: The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial. Br. J. Gen. Pract. (2005) 55(521):924-930.
   PubMed Web of Science ®Google Scholar
• EVERITT HA, LITTLE PS, SMITH PW: A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ (2006) 333(7563):321.
   PubMed Web of Science ®Google Scholar
• DAROUGAR S, QUINLAN MP, GIBSON JA, JONES BR: Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. Br. J. Ophthalmol. (1977) 61(2):76-85.
   PubMed Web of Science ®Google Scholar
• DAROUGAR S, WALPITA P, THAKER U, VISWALINGAM N, GARDNER L, MCSWIGGAN DA: Adenovirus serotypes isolated from ocular infections in London. Br. J. Ophthalmol. (1983) 67(2):111-114.
   PubMed Web of Science ®Google Scholar
• COOPER RJ, HALLETT R, TULLO AB, KLAPPER PE: The epidemiology of adenovirus infections in Greater Manchester, UK 1982 – 1996. Epidemiol. Infect. (2000) 125(2):333-345.
   PubMed Web of Science ®Google Scholar
• CHUANG YY, CHIU CH, WONG KS et al.: Severe adenovirus infection in children. J. Microbiol. Immunol. Infect. (2003) 36:1-40.
   PubMedGoogle Scholar
• PATRIARCA PA, ONORATO IM, SKLAR VE et al.: Acute hemorrhagic conjunctivitis investigation of a large-scale community outbreak in Dade County, Florida. JAMA (1983) 249(10):1283-1289.
   PubMed Web of Science ®Google Scholar
• WOLKEN SH: Acute hemorrhagic conjunctivitis. Surv. Ophthalmol. (1974) 19(2):71-84 (Review).
   PubMedGoogle Scholar
• HOFFMAN M: Acute haemorrhagic conjunctivitis. S. Afr. Med. J. (1982) 62(10):311-312.
   PubMed Web of Science ®Google Scholar
• WEBER CM, EICHENBAUM JW: Acute red eye: differentiating viral conjunctivitis from other, less common causes. Postgrad. Med. (1997) 101(5):185.
   PubMed Web of Science ®Google Scholar
• SHELDRICK JH, VERNON SA, WILSON A: Study of diagnostic accord between general practitioners and an ophthalmologist. BMJ (1992) 304(6834):1096-1098.
   PubMed Web of Science ®Google Scholar
• JACKSON WB: Differentiating conjunctivitis of diverse origins. Surv. Ophthalmol. (1993) 38(Suppl.):91-104.
   PubMed Web of Science ®Google Scholar
• RIETVELD RP, TER RIET G, BINDELS PJ, SLOOS JH, VAN WEERT HC: Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ (2004) 329(7459):206-210.
   PubMed Web of Science ®Google Scholar
• BENEZRA D: Current practice: diagnosis and treatment in primary healthcare. Allergy (1995) 50(21 Suppl.):30-33; discussion 34-38.
   PubMed Web of Science ®Google Scholar
• SAITOH-INAGAWA W, AOKI K, UCHIO E, ITOH N, OHNO S: Ten years' surveillance of viral conjunctivitis in Sapporo, Japan. Graefes. Arch. Clin. Exp. Ophthalmol. (1999) 237(1):35-38.
   PubMed Web of Science ®Google Scholar
• BLOOM HR, ZYZANSKI SJ, KELLEY L, TAPOLYAI A, STANGE KC: Clinical judgment predicts culture results in upper respiratory tract infections. J. Am. Board Fam. Pract. (2002) 15(2):93-100.
   PubMedGoogle Scholar
• RIETVELD RP, VAN WEERT HC, TER RIET G, BINDELS PJ: Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. BMJ (2003) 327(7418):789.
   PubMed Web of Science ®Google Scholar
• FITCH CP, RAPOZA PA, OWENS S et al.: Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology (1989) 96(8):1215-1220.
   PubMed Web of Science ®Google Scholar
• GIGLIOTTI F, WILLIAMS WT, HAYDEN FG et al.: Etiology of acute conjunctivitis in children. J. Pediatr. (1981) 98(4):531-536.
   PubMed Web of Science ®Google Scholar
• BARNARD DL, HART JC, MARMION VJ, CLARKE SK: Outbreak in Bristol of conjunctivitis caused by adenovirus type 8, and its epidemiology and control. BMJ (1973) 2(5859):165-169.
   PubMed Web of Science ®Google Scholar
• KEENLYSIDE RA, HIERHOLZER JC, D'ANGELO LJ: Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist's office. J. Infect. Dis. (1983) 147(2):191-198.
   PubMed Web of Science ®Google Scholar
• MARTIN M, TURCO JH, ZEGANS ME et al.: An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N. Engl. J. Med. (2003) 348(12):1112-1121.
   PubMed Web of Science ®Google Scholar
• AZAR MJ, DHALIWAL DK, BOWER KS, KOWALSKI RP, GORDON YJ: Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am. J. Ophthalmol. (1996) 121(6):711-712.
   PubMed Web of Science ®Google Scholar
• ANSARI SA, SPRINGTHORPE VS, SATTAR SA, RIVARD S, RAHMAN M: Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J. Clin. Microbiol. (1991) 29(10):2115-2119.
   Google Scholar
• SHEIKH A, HURWITZ B: Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst. Rev. (2006) (2):CD001211.
   Google Scholar
• THE OFLOXACIN STUDY GROUP III: A placebo-controlled clinical study of the fluoroquinolone ofloxacin in patients with external ocular infection. Investig. Ophthalmol. Vis. Sci. (1990) 31(4):572.
   Google Scholar
• LEIBOWITZ HM, PRATT MV, FLAGSTAD IJ, BERROSPI AR, KUNDSIN R: Human conjunctivitis. II. Treatment. Arch. Ophthalmol. (1976) 94(10):1752-1756.
   PubMed Web of Science ®Google Scholar
• HORVEN I: Acute conjuctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol. Acta Ophthalmol. (Copenh.) (1993) 71(2):165-168.
   Google Scholar
• CARR WD: Comparison of Fucithalmic (fusidic acid viscous eye drops 1%) and Chloromycetin Redidrops (chloramphenicol eye drops 0.5%) in the treatment of acute bacterial conjunctivitis. J. Clin. Res. (1998) 1(403-411):403-411.
   Google Scholar
• DE HOOG AR: Norfloxacin 0.3% (Chibroxol(TM)) eyedrop; survey in general practice. TGO – Tijdschrift voor Therapie Geneesmiddel en Onderzoek (1993) 18(2):46-50.
   Google Scholar
• CAGLE G, DAVIS S, ROSENTHAL A, SMITH J: Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study. Curr. Eye Res. (1981) 1(9):523-534.
   PubMed Web of Science ®Google Scholar
• LEIBOWITZ HM, HYNDIUK RA, SMOLIN GR et al.: Tobramycin in external eye disease: a double-masked study vs. gentamicin. Curr. Eye Res. (1981) 1(5):259-266.
   PubMed Web of Science ®Google Scholar
• WILSON LA, WEINSTEIN AJ, WOOD TO et al.: Treatment of external eye infections: a double-masked trial of tobramycin and gentamicin. J. Ocular Ther. Surg. (1982) 1:6-367.
   Google Scholar
• DIRDAL M: Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops. Acta Ophthalmol. (Copenh.) (1987) 65(2):129-133.
   Google Scholar
• HVIDBERG J: Fusidic acid in acute conjunctivitis. Single-blind, randomized comparison of fusidic acid and chloramphenicol viscous eye drops. Acta Ophthalmol. (1987) 65:1-47.
   Web of Science ®Google Scholar
• MALMINIEMI K, KARI O, LATVALA ML, VOUTILAINEN R, MIETTINEN A, JAUCH A: Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis. Acta Ophthalmol. Scand. (1996) 74:3-284.
   PubMedGoogle Scholar
• PAPA V, ARAGONA P, SCUDERI AC et al.: Treatment of acute bacterial conjunctivitis with topical netilmicin. Cornea (2002) 21(1):43-47.
   PubMed Web of Science ®Google Scholar
• GARLASCHI ML, RUSCONI F, COLOMBO R et al.: Antimicrobial resistance among clinical isolates of Haemophilus influenzae in northern Italy. Collaborative study on pediatric infectious diseases. Eur. J. Epidemiol. (1993) 9(1):64-69.
   PubMed Web of Science ®Google Scholar
• BLOCK SL, HEDRICK J, TYLER R et al.: Increasing bacterial resistance in pediatric acute conjunctivitis (1997 – 1998). Antimicrob. Agents Chemother. (2000) 44(6):1650-1654.
   PubMed Web of Science ®Google Scholar
• ROBINSON N, MILLER M, LEVETT PN: Antimicrobial sensitivity of Haemophilus influenzae isolates from bacterial conjunctivitis. West Indian Med. J. (2001) 50(2):137-139.
   PubMed Web of Science ®Google Scholar
• WALL AR, SINCLAIR N, ADENIS JP: Comparison of Fucithalmic (fusidic acid viscous eye drops 1%) and Noroxin (norfloxacin ophthalmic solution 0.3%) in the treatment of acute bacterial conjunctivitis. J. Clin. Res. (1998) 1:316-325.
   Google Scholar
• DOONA M, WALSH JB: Use of chloramphenicol as topical eye medication: time to cry halt? BMJ (1995) 310(6989):1217-1218.
   PubMed Web of Science ®Google Scholar
• LANCASTER T, SWART AM, JICK H: Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ (1998) 316(7132):667.
   PubMed Web of Science ®Google Scholar
• GIGLIOTTI F, HENDLEY JO, MORGAN J, MICHAELS R, DICKENS M, LOHR J: Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J. Pediatr. (1984) 104(4):623-626.
   PubMed Web of Science ®Google Scholar
• MILLER IM, WITTREICH J, VOGEL R, COOK TJ: The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group. Eur. J. Ophthalmol. (1992) 2(2):58-66.
   PubMedGoogle Scholar
• GENEE E, SCHLECHTWEG C, BAUERREISS P, GIBSON JR: Trimethoprim-polymyxin eye drops versus neomycin-polymyxin-gramicidin eye drops in the treatment of presumptive bacterial conjunctivitis – a double-blind study. Ophthalmologica (1982) 184(2):92-96.
   PubMed Web of Science ®Google Scholar
• VAN RENSBURG SF, GIBSON JR, HARVEY SG, BURKE CA: Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis. Pharmatherapeutica (1982) 3(4):274-277.
   PubMedGoogle Scholar
• LAMBERTS DW, BUKA T, KNOWLTON GM: Clinical evaluation of trimethoprim-containing ophthalmic solutions in humans. Am. J. Ophthalmol. (1984) 98:1-16.
   PubMed Web of Science ®Google Scholar
• BEHRENS-BAUMANN W, QUENTIN CD, GIBSON JR, CALTHROP JG, HARVEY SG, BOOTH K: Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment. Curr. Med. Res. Opin. (1988) 11(4):227-231.
   PubMed Web of Science ®Google Scholar
• THE TRIMETHOPRIM-POLYMYXIN B SULPHATE OPTHALMIC OINTMENT STUDY GROUP: Trimethoprim-polymyxin B sulphate opthalmic ointment versus chloramphenicol opthalmic ointment in the treatment of bacterial conjunctivitis – a review of four clinical studies. J. Antimicrob. Chemother. (1989) 23:261-266.
   PubMedGoogle Scholar
• MILLER IM, WITTREICH JM, COOK T, VOGEL R: The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group. Eye (1992) 6(Part 1):111-114.
   PubMed Web of Science ®Google Scholar
• MILLER IM, VOGEL R, COOK TJ, WITTREICH J: Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group. Am. J. Ophthalmol. (1992) 113(6):638-644.
   PubMed Web of Science ®Google Scholar
• AGIUS FA, PATTERSON A, FSADNI M, JAUCH A, RAJ PS: Topical lomefloxacin versus topical chloramphenicol in the treatment of acute bacterial conjunctivitis. Clin. Drug Invest. (1998) 15:4-269.
   Google Scholar
• GALLENGA PE, LOBEFALO L, COLANGELO L et al.: Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: a multicenter double-blind Phase III study. Ophthalmologica (1999) 213(4):250-257.
   PubMed Web of Science ®Google Scholar
• KETTENMEYER A, JAUCH A, BOSCHER M et al.: A double-blind double-dummy multicenter equivalence study comparing topical Lomefloxacin 0.3% twice daily with Norfloxacin 0.3% four times daily in the treatment of acute bacterial conjunctivitis. J. Clin. Res. (1975); J. Clin. Res. (1998) 1:75-86.
   Google Scholar
• MONTERO J, CASADO A, PEREA E et al.: A double-blind double-dummy comparison of topical lomefloxacin 0.3% twice daily with topical gentamicin 0.3% four times daily in the treatment of acute bacterial conjunctivitis. J. Clin. Res. (1998) 1:29-39.
   Google Scholar
• TIMEWELL RM, ROSENTHAL AL, SMITH JP, CAGLE GD: Safety and efficacy of tobramycin and gentamicin sulfate in the treatment of external ocular infections of children. J. Pediatr. Ophthamol. Strabismus (1983) 20:1-26.
   Google Scholar
• LOHR JA, AUSTIN RD, GROSSMAN M, HAYDEN GF, KNOWLTON GM, DUDLEY SM: Comparison of three topical antimicrobials for acute bacterial conjunctivitis. Pediatr. Infect. Dis. J. (1988) 7(9):626-629.
   PubMed Web of Science ®Google Scholar
• GROSS RD, HOFFMAN RO, LINDSAY RN: A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children. Clin. Pediatr. (Phila.) (1997) 36(8):435-444.
   PubMed Web of Science ®Google Scholar
• WALD ER, GREENBERG D, HOBERMAN A: Short term oral cefixime therapy for treatment of bacterial conjunctivitis. Pediatr. Infect. Dis. J. (2001) 20(11):1039-1042.
   PubMed Web of Science ®Google Scholar
• RUSHFORD WA, HOLMAN RM, PULVERTAFT TB: Tanderil/chloramphenicol eye ointment in the treatment of the “Red Eye” seen in general practice. J. Int. Med. Res. (1978) 6(2):141-143.
   PubMed Web of Science ®Google Scholar
• HOBSON D, STEFANIDIS D, REES E, TAIT IA: Effects of chloramphenicol on Chlamydia trachomatis infection in neonatal conjunctivitis and in McCoy cell cultures. J. Hyg. (Lond.) (1982) 89(3):457-466.
   PubMedGoogle Scholar
• POWER WJ, COLLUM LMT, EASTY DL et al.: Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol. Eur. J. Ophthalmol. (1993) 3:2-82.
   Google Scholar
• BLOOM PA, LEEMING JP, POWER W, LAIDLAW DAH, COLLUM LMT, EASTY DL: Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis. Eur. J. Ophthalmol. (1994) 4:1-12.
   PubMedGoogle Scholar
• ADENIS JP, COLIN J, VERIN P, SAINT-BLANCAT P, MALET F: Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis. Eur. J. Ophthalmol. (1995) 5(2):82-87.
   PubMedGoogle Scholar
• CHISARI G, REIBALDI M: Ciprofloxacin as treatment for conjunctivitis. J. Chemother. (2004) 16(2):156-159.
   PubMed Web of Science ®Google Scholar
• CHALITA MR, HOFLING-LIMA AL, PARANHOS A Jr, SCHOR P, BELFORT R Jr: Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am. J. Ophthalmol. (2004) 137(1):43-51.
   PubMed Web of Science ®Google Scholar
• BUZNACH N, DAGAN R, GREENBERG D: Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr. Infect. Dis. J. (2005) 24(9):823-828.
   PubMed Web of Science ®Google Scholar
• MILLER IM, WITTREICH JM, COOK T, VOGEL R: The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group. Eye (1992) 6(Part 1):111-114.
   PubMed Web of Science ®Google Scholar
• ISENBERG SJ, APT L, VALENTON M et al.: A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am. J. Opthalmol. (2002) 134:681-688.
   PubMed Web of Science ®Google Scholar